Treatment of irritable bowel syndrome with loperamide oxide. An open study to determine optimal dosage.
Ragnarsson
G
G
Bodemar
G
G
D000328:Adult; D000930:Antidiarrheals / Q000008:administration & dosage*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008139:Loperamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D016896:Treatment Outcome
D000930:Antidiarrheals; D008139:Loperamide; C066043:loperamide oxide